Protein– tag –
-
Identifying Blood-Brain Barrier (BBB) Bottleneck: Nanomedicine Key to Overcoming Glioblastoma Brain Drug Delivery Challenges
Neuroscience News Unknown Overview The blood-brain barrier (BBB), a major obstacle to brain drug delivery, severely limits therapies for neurological disorders like glioblastoma. Recent research identified intracellular sorting after dru... -
McKinsey Report: Generative AI and Foundation Models Revolutionize Biopharma R&D Workflow, Accelerating Molecular Design and Antibody Engineering
McKinsey Unknown Overview A McKinsey report highlights that generative AI and foundation models are revolutionizing biopharma R&D workflows. These AI models design novel molecular structures, experimental hypotheses, and synthetic pa... -
AI-Driven JAM Platform Designs Molecular Binders Beyond GPCR Antibody Generation: Achieves High Hit Rates for CXCR7 and Claudin-4 Targets, AI-Discovered Drugs Advance to Phase IIa
Pharma Focus Asia Unknown Overview The AI-driven JAM platform has surpassed traditional GPCR antibody generation methods, predicting previously overlooked molecular binding interactions. JAM computationally designed binders for multi-tra... -
Ionis’ ASO Therapy Zilganersen Awaits FDA Approval for Alexander Disease: Achieves Primary Endpoints and Granted Priority Review
BioXconomy USA Overview Ionis Pharmaceuticals' antisense oligonucleotide (ASO), zilganersen, is awaiting FDA approval for the ultra-rare neurological disorder, Alexander disease. The pivotal Phase 1-3 trial (NCT04849741) met its primary ... -
BMS Molecular Glue Mezigdomide Combination Therapy Transforms Oncology: Achieves 52% Reduction in Progression or Death Risk in Phase 3 Multiple Myeloma Trial
PMLiVE Unknown Overview Targeted protein degraders (TPDs), specifically PROTACs and molecular glues, are rapidly advancing in oncology. At ASCO, Bristol Myers Squibb (BMS) announced Phase 3 results showing their molecular glue, Mezigdomi... -
Split GFP Fluorescent Biosensors Visualize Real-Time Dynamics of ER-Golgi Membrane Contacts with Super-Resolution Imaging
Research Article UK Overview Researchers have developed gene-encoded fluorescent biosensors utilizing a split GFP/YFP system to specifically label and dynamically observe ER-Golgi membrane contact sites. These advanced probes enable supe... -
DLG Report Details Nanosensor Innovation in Food Industry: FluIDect for Real-time Quality Monitoring, Oxford Nanopore for Pathogen ID
DLG-Expert report Germany Overview According to a DLG expert report, nanosensors significantly enhance accuracy, sensitivity, and speed in food testing by detecting, quantifying, and monitoring chemical, physical, or biological parameter... -
CRP Point-of-Care Testing (POCT) Significantly Reduces Pediatric Antibiotic Prescriptions by 20-30%
Aidian フィンランド Overview New findings from two large-scale randomized controlled trials (COORDINATE and ARON) demonstrate that C-reactive protein (CRP) Point-of-Care Testing (POCT) can safely and effectively guide antibiotic use in c... -
Diversa Technologies Develops Biodegradable Lipid Nanoparticle Platform for Protein Replacement Therapy, Accelerating Next-Gen Therapeutic Development
Diversa Technologies USA Overview Diversa Technologies is developing advanced nanomedicine platforms based on biodegradable lipid nanoparticles for targeted and controlled delivery of therapeutic modalities like mRNA and proteins, accele... -
Bioprocessing Technologies Reshape Food Production, Environmental Applications, and Sustainable Manufacturing Beyond Pharma
Technology Networks Global Overview Bioprocessing technologies are redefining various industries beyond pharmaceuticals, including food production, environmental applications, and sustainable manufacturing. Key technologies like fermenta...
